AquaBounty Technologies Appoints Interim CEO and Announces Ceasing Fish Farming OperationsHarvard, Mass. – AquaBounty Technologies, Inc. (NASDAQ: AQB) disclosed in an 8-K filing that on December 6, 2024, the Board of Directors appointed David Frank a

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read AquaBounty Technologies’s 8K filing here.

About AquaBounty Technologies

(Get Free Report)

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.

Featured Articles